BILH Selected as Inaugural Member of ARPA-H Investor Catalyst Hub Spoke Network
The Nationwide Network Aims to Accelerate Transformative Health Solutions
BOSTON — Beth Israel Lahey Health (BILH) has been selected as an inaugural spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub aims to accelerate the commercialization of practical, accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.
“Beth Israel Lahey Health is a leader in innovation, driven by the goal to deliver the best outcomes for our patients,” said Gyongyi Szabo, MD, PhD, Chief Academic Officer of BILH and Beth Israel Deaconess Medical Center. “We are thrilled to play an inaugural role in the Investor Catalyst Hub and work with research organizations from across the country as we move toward the discovery of new technologies and implementation of new therapies advancing precision medicine.”
BILH joins a dynamic nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through research focusing on health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.
With more than 1,500 researchers involved in approximately 2,700 clinical studies and a $300 million research portfolio, BILH is a national leader in research and innovation. BILH’s research arm operates similarly to the intended structure of the Investor Catalyst Hub with investigators and clinicians across many disciplines working together in specific therapeutic areas called Translational Research Hubs to accelerate discoveries into direct patient care.
“Our spoke network represents a rich and representative range of perspectives and expertise,” said Mark Marino, Vice President of Growth Strategy and Development for VentureWell and Project Director for the Investor Catalyst Hub. “Our spokes comprise a richly diverse network that will be instrumental in ensuring that equitable health solutions reach communities across every state and tribal nation.”
As an Investor Catalyst Hub spoke, BILH gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library. The spoke network will continue to grow as The Investor Catalyst Hub expands its efforts, with applications being selected on a rolling basis.
About Beth Israel Lahey Health
Beth Israel Lahey Health is a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
